Samdal F, Vada K, Lundmo P I, Mjølnerød O K
Department of Urology, Trondheim University Hospital, Norway.
Scand J Urol Nephrol. 1991;25(3):197-9. doi: 10.3109/00365599109107946.
Since January 1989, we have carried out a prospective study about whether patients prefer orchidectomy or medical castration with luteinising hormone releasing hormone analogues for the treatment of prostatic cancer. When the preliminary results were presented, 40 Norwegian urologists were asked which treatment they would prefer if they had advanced cancer of the prostatic gland. Most patients and urologists (65-70%) favoured medical castration.
自1989年1月以来,我们开展了一项前瞻性研究,探究前列腺癌患者更倾向于接受睾丸切除术还是使用促黄体生成素释放激素类似物进行药物去势治疗。在公布初步研究结果时,我们询问了40位挪威泌尿科医生,如果他们患有晚期前列腺癌,会选择哪种治疗方式。大多数患者和泌尿科医生(65%-70%)倾向于药物去势。